111 related articles for article (PubMed ID: 4740227)
1. [Clinical study on the subtoxic full effective and maintenance dose of digoxin under the influence of spironolactone. Studies on the decompensated heart patient].
Krämer KD; Ghabussi P; Hochrein H
Arzneimittelforschung; 1973 Apr; 23(4):508-11. PubMed ID: 4740227
[No Abstract] [Full Text] [Related]
2. [Cardiac therapy using -methyl digoxin].
Rummel W; Niederländer K
Munch Med Wochenschr; 1972 May; 114(19):930-2. PubMed ID: 4559200
[No Abstract] [Full Text] [Related]
3. Spironolactone-digoxin interaction.
Hsieh YY; Lin MS; Chen JH; Hsu KL; Wu TL; Su CT; Shu MY; Hsu JC; Hsu WS; Chen JS
Taiwan Yi Xue Hui Za Zhi; 1983 Jan; 82(1):47-60. PubMed ID: 6575127
[No Abstract] [Full Text] [Related]
4. Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure.
Gao X; Peng L; Adhikari CM; Lin J; Zuo Z
J Card Fail; 2007 Apr; 13(3):170-7. PubMed ID: 17448413
[TBL] [Abstract][Full Text] [Related]
5. [Dose determinations and enteral effectiveness of the pure lanata glycoside digoxine (Lanicor) in decompensated heart disease patients].
Krämer KD; Ghabussi P; Hochrein H
MMW Munch Med Wochenschr; 1974 Aug; 116(35):1505-8. PubMed ID: 4213781
[No Abstract] [Full Text] [Related]
6. [Clinical evaluation of beta-methyldigoxin (Lanitop)].
Ostrowski K; Tracz P
Pol Tyg Lek; 1974 Aug; 29(32):1395-7. PubMed ID: 4848295
[No Abstract] [Full Text] [Related]
7. [Direct positive inotropic influencing on the heart using oral spironolactone therapy].
Schröder R; Ramdohr B; Hüttemann U; von Leitner E; Schüren KP
Verh Dtsch Ges Kreislaufforsch; 1972; 38():349-53. PubMed ID: 4576732
[No Abstract] [Full Text] [Related]
8. [Heart failure therapy with digitalis and spironolactone--studies within the scope of preoperative treatment before lung resection].
Daum S; Goerg R; Mack D; Wang D
Prax Klin Pneumol; 1984 Sep; 38(9):406-11. PubMed ID: 6504840
[No Abstract] [Full Text] [Related]
9. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
[TBL] [Abstract][Full Text] [Related]
10. [Digoxin treatment in general practice].
Iisalo E; Schrey E
Duodecim; 1977; 93(3):198-205. PubMed ID: 844443
[No Abstract] [Full Text] [Related]
11. [New aspects of the use of spironolactone and its association with thiabutazide (per os and in injections) in the treatment of grave cardiac insufficiency].
Căruntu M; Mihail A
Med Interna (Bucur); 1974 Feb; 26(2):177-88. PubMed ID: 4828933
[No Abstract] [Full Text] [Related]
12. Laboratory evaluation of potassium and creatinine among ambulatory patients prescribed spironolactone: are we monitoring for hyperkalemia?
Raebel MA; McClure DL; Chan KA; Simon SR; Feldstein AC; Lafata JE; Andrade SE; Gunter MJ; Nelson WW; Roblin D; Platt R
Ann Pharmacother; 2007 Feb; 41(2):193-200. PubMed ID: 17284506
[TBL] [Abstract][Full Text] [Related]
13. Spironolactone use in patients with heart failure.
Trujillo JM; Gonyeau MJ; DiVall MV; Alexander SL
J Clin Pharm Ther; 2004 Apr; 29(2):165-70. PubMed ID: 15068406
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing medical treatment of heart failure patients in Spanish internal medicine departments: a national survey.
Román-Sánchez P; Conthe P; García-Alegría J; Forteza-Rey J; Montero M; Montoto C
QJM; 2005 Feb; 98(2):127-38. PubMed ID: 15655095
[TBL] [Abstract][Full Text] [Related]
15. [Do we use digitalis properly in the management of elderly patients suffering from the signs of chronic heart failure?].
Erdei F; Vendrey R; Dani G; Kovács E; Márk L; Katona A
Orv Hetil; 2006 Oct; 147(41):1993-6. PubMed ID: 17120690
[TBL] [Abstract][Full Text] [Related]
16. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
Tamirisa KP; Aaronson KD; Koelling TM
Am Heart J; 2004 Dec; 148(6):971-8. PubMed ID: 15632880
[TBL] [Abstract][Full Text] [Related]
17. Heart failure. II.
Br Med J; 1971 Mar; 1(5751):716-8. PubMed ID: 5551250
[No Abstract] [Full Text] [Related]
18. [Determination of the relative enteral activity of beta-methyl-digoxin in patients with heart failure (author's transl)].
Ghabussi P; Krämer KD; Hochrein H
Med Klin; 1974 May; 69(18):802-5. PubMed ID: 4837409
[No Abstract] [Full Text] [Related]
19. [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
Bednarz B; Cybulski J; Chamiec T
Pol Merkur Lekarski; 2000 Aug; 9(50):519-21. PubMed ID: 11081314
[TBL] [Abstract][Full Text] [Related]
20. [Spironolactone in digitalis-requiring cardiac insufficiency following pacemaker implantation].
Sabin G; Klüsener W
Med Klin; 1981 Jan; 76(1):20-3. PubMed ID: 7254119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
